Arcutis Biotherapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ARQT Nasdaq 2830 www.arcutis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arcutis Biotherapeutics, Inc.

Here's Why You Should Add ARQT Stock to Your Portfolio Now - Aug 28th, 2026 8:58 am
Arcutis Biotherapeutics (ARQT) Faces A Valuation Test, Is It Still A Bargain? - Aug 27th, 2026 7:07 pm
Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen - Aug 27th, 2026 2:27 am
5 Biotech Stocks Worth Adding to Your Portfolio Now - Aug 26th, 2026 8:19 am
Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer - Aug 24th, 2026 2:01 pm
Arcutis (ARQT) Q2 2026 Earnings Call Transcript - Aug 12th, 2026 3:28 pm
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Aug 7th, 2026 2:00 pm
Arcutis President and CEO Todd Watanabe Sells 4,375 Shares for $114,275 as Q2 Results Demonstrate Profitability - Aug 6th, 2026 6:50 am
Arcutis Biotherapeutics, Inc. Q2 2026 Earnings Call Summary - Aug 6th, 2026 6:30 am
Arcutis Biotherapeutics Inc (ARQT) (Q2 2026) Earnings Call Highlights: Revenue Surges 59% and ... - Aug 5th, 2026 11:08 pm
Arcutis Biotherapeutics Q2 Earnings Call Highlights - Aug 5th, 2026 4:03 pm
Arcutis Biotherapeutics, Inc. (ARQT) Q2 Earnings and Revenues Surpass Estimates - Aug 5th, 2026 3:10 pm
Arcutis Announces Second Quarter 2026 Financial Results and Provides Business Update - Aug 5th, 2026 2:00 pm
Viatris Gears Up to Report Q2 Earnings: What's in the Cards? - Aug 4th, 2026 9:37 am
Outlook Therapeutics to Report Q3 Earnings: What's in the Cards? - Aug 3rd, 2026 8:58 am
4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates - Aug 3rd, 2026 8:34 am
Arcutis Biotherapeutics (ARQT) Stock Trades At A Discount To Sales But Fair Value Looks Tight - Jul 31st, 2026 9:10 am
Arcutis Biotherapeutics (ARQT) Heads Into Earnings With Its ZORYVE Story Still Shaping Valuation - Jul 31st, 2026 12:08 am